Early research (Phase 1)Study completedNCT05681819
What this trial is testing
SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 33